COMMUNIQUÉS West-GlobeNewswire

Pacific Biosciences of California, Inc. Announces Second Quarter 2018 Financial Results

02/08/2018 - 22:01

MENLO PARK, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2018. Total revenue for the second [...]

IntelGenx to Report Second Quarter 2018 Financial Results on Aug 9, 2018 – Conference Call to Follow

02/08/2018 - 22:00

SAINT LAURENT, Quebec, Aug. 02, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) today announced that it will release its second quarter 2018 financial results after market close on [...]

Arbutus Reports 2018 Second Quarter Financial Results and Provides Corporate Update

02/08/2018 - 22:00

- Phase 1a/1b study of AB-506, a second-generation oral capsid inhibitor, initiated - Phase 1a/1b study of AB-452, a novel and proprietary oral RNA destabilizer, expected to begin in the second half of 2018 - All oral [...]

MannKind Corporation Reports 2018 Second Quarter Financial Results Conference Call to Begin Today at 5:00 PM ET

02/08/2018 - 22:00

2Q 2018 Afrezza Net Revenue was $3.8 million; 142% growth versus 2Q 2017 2Q 2018 Afrezza TRx grew 71% versus 2Q 2017 Debt principal reduced by $42.6 million, or 27%, year-to-date Successfully completed Phase 1 clinical [...]

Capricor Therapeutics to Present Second Quarter Financial Results and Corporate Update on August 9

02/08/2018 - 22:00

LOS ANGELES, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of [...]

Tauriga Sciences Inc. Notified by FINRA that its Ticker Symbol will Revert to TAUG at Open of Market on Friday August 3, 2018

02/08/2018 - 21:07

NEW YORK, NY, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB: TAUG) (OTCQB: TAUGD) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]

MPX Bioceutical Corporation Reports Financial Results for Its Fiscal Year 2018

02/08/2018 - 21:02

Company reports FY 2018 revenues of $21.3 million TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) today reports financial results for its fiscal [...]

Bonify Signs Cannabis Concentrate Program Agreement With MediPharm Labs Inc.

02/08/2018 - 20:36

TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Inc. (" MediPharm " or the " Company ") is pleased to announce that it has entered into a Cannabis Concentrate Program Agreement dated July 31, 2018 (the " [...]

Phase 2 Clinical Data Published Showing Summit’s Ridinilazole Preserved the Gut Microbiome of Patients with C. difficile Infection

02/08/2018 - 20:00

Microbiome Damage Caused by Current Treatments May Lead to Disease Recurrence Ridinilazole Reduced Recurrence Rates by 59% versus Standard of Care Vancomycin OXFORD, U.K. and CAMBRIDGE, Mass., Aug. 02, 2018 (GLOBE [...]

CohBar, Inc. to Announce 2018 Second Quarter Financial Results and Host Conference Call for Shareholders on August 14, 2018

02/08/2018 - 19:09

MENLO PARK, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today [...]

New Trump Administration Rules to Increase Patient Options Are Welcome Relief, States the Association of American Physicians and Surgeons (AAPS)

02/08/2018 - 17:38

TUCSON, Ariz., Aug. 02, 2018 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeon applauds the Trump Administration’s decision on August 1 to finalize expanded flexibility for short term, limited [...]

Tempus to Participate in the NCI-MATCH Clinical Trial

02/08/2018 - 16:30

Having met rigorous qualifications, Tempus joins a select group of commercial and academic laboratories designated to cast a wider net for patients to enter the trial CHICAGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Tempus [...]

Misonix to Present at the 38th Annual Canaccord Genuity Growth Conference on August 8

02/08/2018 - 16:30

FARMINGDALE, N.Y., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]

UPDATE: Medifirst Solutions Announces New Consulting Agreement for Its Specialty Drug Division

02/08/2018 - 16:06

Freehold, NJ, Aug. 02, 2018 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (OTC: MFSTD) (the “Company” or “Medifirst”), a provider of innovative laser technology and specialty pharmacy drug and consulting [...]

Medifirst Solutions Announces New Consulting Agreement for Its Specialty Drug Division

02/08/2018 - 15:20

Freehold, NJ, Aug. 02, 2018 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology and specialty pharmacy drug and consulting services, is [...]

Sienna Biopharmaceuticals Appoints Finance Veteran, James M. Hindman, to Board of Directors

02/08/2018 - 15:05

-- Hindman will chair Sienna’s Audit Committee WESTLAKE VILLAGE, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), a clinical-stage medical dermatology and aesthetics company, [...]

Transforming the Service Experience Helps Konica Minolta Healthcare Maintain its Leadership in Customer Satisfaction

02/08/2018 - 15:00

WAYNE, N.J., Aug. 02, 2018 (GLOBE NEWSWIRE) -- At Konica Minolta Healthcare Americas, Inc., a customer-centric approach is evident by the company’s consistent top ratings from MD Buyline for its exceptional digital [...]

Valens GroWorks Sets the Table for International Cannabis Markets -- CFN Media

02/08/2018 - 15:00

SEATTLE, Aug. 02, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]

Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock

02/08/2018 - 15:00

SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic [...]